Mengqiu Wu

1.0k total citations
39 papers, 839 citations indexed

About

Mengqiu Wu is a scholar working on Molecular Biology, Nephrology and Oncology. According to data from OpenAlex, Mengqiu Wu has authored 39 papers receiving a total of 839 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Nephrology and 6 papers in Oncology. Recurrent topics in Mengqiu Wu's work include Chronic Kidney Disease and Diabetes (4 papers), Air Quality and Health Impacts (3 papers) and Metabolomics and Mass Spectrometry Studies (3 papers). Mengqiu Wu is often cited by papers focused on Chronic Kidney Disease and Diabetes (4 papers), Air Quality and Health Impacts (3 papers) and Metabolomics and Mass Spectrometry Studies (3 papers). Mengqiu Wu collaborates with scholars based in China, Australia and Hong Kong. Mengqiu Wu's co-authors include Haiping Hao, Guangji Wang, Aihua Zhang, Zhanjun Jia, Songming Huang, Xuefang Cheng, Yue Zhang, Lijuan Cao, Hong Wang and Chang Shao and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Analytical Chemistry.

In The Last Decade

Mengqiu Wu

38 papers receiving 828 citations

Peers

Mengqiu Wu
Jinghui Zhai China
Abdel‐Aziz H. Abdel‐Aziz Egypt
Tong‐Tong Liu China
Jianling Liu China
Xiaoye Fan China
Cheng‐Tien Wu Taiwan
Xuhua Ge China
Zeeshan Javed Pakistan
Lifang Ye China
Dezhao Lu China
Jinghui Zhai China
Mengqiu Wu
Citations per year, relative to Mengqiu Wu Mengqiu Wu (= 1×) peers Jinghui Zhai

Countries citing papers authored by Mengqiu Wu

Since Specialization
Citations

This map shows the geographic impact of Mengqiu Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengqiu Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengqiu Wu more than expected).

Fields of papers citing papers by Mengqiu Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengqiu Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengqiu Wu. The network helps show where Mengqiu Wu may publish in the future.

Co-authorship network of co-authors of Mengqiu Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Mengqiu Wu. A scholar is included among the top collaborators of Mengqiu Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengqiu Wu. Mengqiu Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Mengqiu, Yuting Li, Jiaojiao Fan, et al.. (2025). Targeting renal tubular WWP2 to restore mitochondrial OXPHOS integrity retards the AKI-to-CKD transition. Molecular Therapy. 34(3). 1576–1596. 1 indexed citations
2.
Xu, Xinyue, Qianqian Jin, Yuting Li, et al.. (2025). Interferon regulatory factor 5 attenuates kidney fibrosis through transcriptional suppression of Tgfbr1. International Immunopharmacology. 148. 114031–114031. 1 indexed citations
3.
4.
Xu, Xinyue, Mi Bai, Jiaojiao Fan, et al.. (2024). Activation of LONP1 by 84-B10 alleviates aristolochic acid nephropathy via re-establishing mitochondrial and peroxisomal homeostasis. Chinese Journal of Natural Medicines. 22(9). 808–821. 2 indexed citations
5.
Wu, Mengqiu, Qianqian Jin, Xinyue Xu, et al.. (2023). TP53RK Drives the Progression of Chronic Kidney Disease by Phosphorylating Birc5. Advanced Science. 10(25). e2301753–e2301753. 5 indexed citations
6.
Li, Yuting, et al.. (2023). Therapeutic Potential Targeting Podocyte Mitochondrial Dysfunction in Focal Segmental Glomerulosclerosis. SHILAP Revista de lepidopterología. 9(4). 254–264. 12 indexed citations
7.
Bai, Mi, Mengqiu Wu, Mingzhu Jiang, et al.. (2023). LONP1 targets HMGCS2 to protect mitochondrial function and attenuate chronic kidney disease. EMBO Molecular Medicine. 15(2). e16581–e16581. 48 indexed citations
8.
Hu, Hua, Mengqiu Wu, Tong Wu, et al.. (2023). Reduction of NADPH oxidase 4 in adipocytes contributes to the anti-obesity effect of dihydroartemisinin. Heliyon. 9(3). e14028–e14028. 6 indexed citations
9.
10.
Fan, Jiaojiao, Xinyue Xu, Yuting Li, et al.. (2022). A novel 3-phenylglutaric acid derivative (84-B10) alleviates cisplatin-induced acute kidney injury by inhibiting mitochondrial oxidative stress-mediated ferroptosis. Free Radical Biology and Medicine. 194. 84–98. 20 indexed citations
11.
Liu, Xiangtong, Zhiwei Li, Jie Zhang, et al.. (2021). The association between ozone and ischemic stroke morbidity among patients with type 2 diabetes in Beijing, China. The Science of The Total Environment. 818. 151733–151733. 16 indexed citations
12.
Liu, Mengmeng, Zhiwei Li, Feng Lu, et al.. (2021). Acute effect of particulate matter pollution on hospital admissions for cause-specific respiratory diseases among patients with and without type 2 diabetes in Beijing, China, from 2014 to 2020. Ecotoxicology and Environmental Safety. 226. 112794–112794. 7 indexed citations
13.
Zhao, Min, Dandan Wang, Yuan Che, et al.. (2017). Ginsenosides synergize with mitomycin C in combating human non-small cell lung cancer by repressing Rad51-mediated DNA repair. Acta Pharmacologica Sinica. 39(3). 449–458. 13 indexed citations
14.
Wu, Mengqiu, Hui Ye, Zhiyuan Tang, et al.. (2017). p53 dynamics orchestrates with binding affinity to target genes for cell fate decision. Cell Death and Disease. 8(10). e3130–e3130. 40 indexed citations
15.
Wu, Mengqiu, Hui Ye, Chang Shao, et al.. (2017). Metabolomics–Proteomics Combined Approach Identifies Differential Metabolism-Associated Molecular Events between Senescence and Apoptosis. Journal of Proteome Research. 16(6). 2250–2261. 35 indexed citations
16.
Xie, Yang, Hong Wang, Xuefang Cheng, et al.. (2016). Farnesoid X receptor activation promotes cell proliferation via PDK4-controlled metabolic reprogramming. Scientific Reports. 6(1). 18751–18751. 29 indexed citations
17.
Zheng, Xiao, Kang An, Mengqiu Wu, et al.. (2016). Chemical dampening of Ly6Chi monocytes in the periphery produces anti-depressant effects in mice. Scientific Reports. 6(1). 19406–19406. 41 indexed citations
18.
19.
20.
Liu, Miao, Qiong Wang, Fang Liu, et al.. (2013). UDP-Glucuronosyltransferase 1A Compromises Intracellular Accumulation and Anti-Cancer Effect of Tanshinone IIA in Human Colon Cancer Cells. PLoS ONE. 8(11). e79172–e79172. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinghui Zhai Breakdown of academic impact, for papers by Abdel‐Aziz H. Abdel‐Aziz Breakdown of academic impact, for papers by Tong‐Tong Liu Breakdown of academic impact, for papers by Jianling Liu Breakdown of academic impact, for papers by Xiaoye Fan Breakdown of academic impact, for papers by Cheng‐Tien Wu Breakdown of academic impact, for papers by Xuhua Ge Breakdown of academic impact, for papers by Zeeshan Javed Breakdown of academic impact, for papers by Lifang Ye Breakdown of academic impact, for papers by Dezhao Lu
Rankless by CCL
2026